INDAZOLE MACROCYCLE POLYMORPHS
PE0017292026A1Pending Publication Date: 2026-08-31BLOSSOMHILL THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- PE2026001809
- Authority / Receiving Office
- PE · PE
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-06
- Filing Date
- 2024-12-06
- Publication Date
- 2026-08-31
Abstract
It refers to polymorphs of (17E)-16-ethyl-8,12,14-trimethyl-2,11,12,14-tetrahydro-8H-3,5-ethenotripyrazolo[3,4-f:3',4'-j:4'',3''-n][1,4]oxazacyclopentadecin-13(10H)-one that are useful in the treatment of diseases, such as cancer, in mammals. It also refers to compositions that include such polymorphs and methods for using such compositions in the treatment of diseases, such as cancer, in mammals, especially humans.
Need to check novelty before this filing date? Find Prior Art